Annual Accounts Receivable
$218.00 K
-$468.00 K-68.22%
31 December 2021
Summary:
Concert Pharmaceuticals annual accounts receivable is currently $218.00 thousand, with the most recent change of -$468.00 thousand (-68.22%) on 31 December 2021. During the last 3 years, it has fallen by -$468.00 thousand (-68.22%).CNCE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$1.44 M
+$368.00 K+34.33%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly accounts receivable is currently $1.44 million, with the most recent change of +$368.00 thousand (+34.33%) on 30 September 2022.CNCE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -68.2% | +202.5% |
| 5 y5 years | +1353.3% | +10000.0% |
CNCE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -78.6% | at high |
Concert Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $1.44 M(+34.3%) |
| June 2022 | - | $1.07 M(+44.1%) |
| Mar 2022 | - | $744.00 K(+241.3%) |
| Dec 2021 | $218.00 K(-68.2%) | $218.00 K(-54.2%) |
| Sept 2021 | - | $476.00 K(+98.3%) |
| June 2021 | - | $240.00 K(+203.8%) |
| Mar 2021 | - | $79.00 K(-88.5%) |
| Dec 2020 | $686.00 K(+852.8%) | $686.00 K(+427.7%) |
| Sept 2020 | - | $130.00 K(+160.0%) |
| June 2020 | - | $50.00 K(+4900.0%) |
| Mar 2020 | - | $1000.00(-98.6%) |
| Dec 2019 | $72.00 K(+380.0%) | $72.00 K(+554.5%) |
| Sept 2019 | - | $11.00 K(-71.1%) |
| June 2019 | - | $38.00 K(+245.5%) |
| Mar 2019 | - | $11.00 K(-26.7%) |
| Dec 2018 | $15.00 K(-90.3%) | $15.00 K(-89.6%) |
| Sept 2018 | - | $144.00 K(+476.0%) |
| June 2018 | - | $25.00 K(-80.5%) |
| Mar 2018 | - | $128.00 K(-17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $155.00 K(+474.1%) | $155.00 K(+1837.5%) |
| Sept 2017 | - | $8000.00(-97.1%) |
| June 2017 | - | $273.00 K(+1505.9%) |
| Mar 2017 | - | $17.00 K(-37.0%) |
| Dec 2016 | $27.00 K(-61.4%) | $27.00 K(+28.6%) |
| Sept 2016 | - | $21.00 K(-84.2%) |
| June 2016 | - | $133.00 K(-12.5%) |
| Mar 2016 | - | $152.00 K(+117.1%) |
| Dec 2015 | $70.00 K(-93.1%) | $70.00 K(-48.5%) |
| Sept 2015 | - | $136.00 K(+46.2%) |
| June 2015 | - | $93.00 K(-27.9%) |
| Mar 2015 | - | $129.00 K(-87.4%) |
| Dec 2014 | $1.02 M(+500.6%) | $1.02 M(-18.0%) |
| Sept 2014 | - | $1.25 M(+1196.9%) |
| June 2014 | - | $96.00 K(+41.2%) |
| Mar 2014 | - | $68.00 K(-60.0%) |
| Dec 2013 | $170.00 K(+1207.7%) | $170.00 K(+3.7%) |
| Sept 2013 | - | $164.00 K(+1161.5%) |
| Dec 2012 | $13.00 K(-97.4%) | $13.00 K |
| Dec 2011 | $500.00 K | - |
FAQ
- What is Concert Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of CNCE is $218.00 K
What is the all time high annual accounts receivable for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual accounts receivable is $1.02 M
What is Concert Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of CNCE is $1.44 M
What is the all time high quarterly accounts receivable for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly accounts receivable is $1.44 M